AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionVan Eck Associates Corp
Latest Disclosed Ownership259,354 shares
Latest Disclosed Value $ 56,407
Van Eck Associates Corp reports 4.42% decrease in ownership of ABBV / AbbVie Inc.

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 259,354 shares of AbbVie Inc. (US:ABBV) valued at $56,406,901 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 271,348 shares of AbbVie Inc.. This represents a change in shares of -4.42% during the quarter. The current value of the position is $56,313,534 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AbbVie COM 00287Y109 259,354 -11,994 -4.42 56 -9.68 0.0370
2026-02-13 2025-12-31 13F AbbVie COM 00287Y109 271,348 131,515 94.05 62 93.75 0.0512
2025-11-13 2025-09-30 13F AbbVie COM 00287Y109 139,833 -27,126 -16.25 32 6.67 0.0301
2025-08-14 2025-06-30 13F AbbVie COM 00287Y109 166,959 -63,645 -27.60 31 -37.50 0.0351
2025-05-15 2025-03-31 13F AbbVie COM 00287Y109 230,604 -26,909 -10.45 48 6.67 0.0625
2025-01-29 2024-12-31 13F AbbVie COM 00287Y109 257,513 5,863 2.33 46 -4.26 0.0586
2024-10-29 2024-09-30 13F AbbVie COM 00287Y109 251,650 25,248 11.15 47 23.68 0.0590
2024-07-31 2024-06-30 13F AbbVie COM 00287Y109 226,402 9,105 4.19 39 -2.56 0.0552
2024-04-30 2024-03-31 13F AbbVie COM 00287Y109 217,297 49,284 29.33 40 50.00 0.0598
2024-02-05 2023-12-31 13F AbbVie COM 00287Y109 168,013 -893 -0.53 26 4.00 0.0474
2023-11-08 2023-09-30 13F AbbVie COM 00287Y109 168,906 10,015 6.30 25 19.05 0.0553
2023-08-03 2023-06-30 13F AbbVie COM 00287Y109 158,891 1,537 0.98 21 -16.00 0.0468
2023-05-03 2023-03-31 13F AbbVie COM 00287Y109 157,354 -65,003 -29.23 25 -28.57 0.0571
2023-02-08 2022-12-31 13F AbbVie COM 00287Y109 222,357 -73,685 -24.89 36 -99.91 0.0928
2022-10-27 2022-09-30 13F AbbVie COM 00287Y109 296,042 20,135 7.30 39,732 -5.98 0.1182
2022-08-03 2022-06-30 13F AbbVie COM 00287Y109 275,907 45,678 19.84 42,258 13.23 0.1120
2022-05-10 2022-03-31 13F AbbVie COM 00287Y109 230,229 12,513 5.75 37,322 26.61 0.0770
2022-01-26 2021-12-31 13F AbbVie COM 00287Y109 217,716 -15,023 -6.45 29,478 17.41 0.0682
2021-11-03 2021-09-30 13F AbbVie COM 00287Y109 232,739 59,097 34.03 25,106 28.36 0.0631
2021-08-10 2021-06-30 13F AbbVie COM 00287Y109 173,642 -210,029 -54.74 19,559 -52.89 0.0463
2021-05-13 2021-03-31 13F AbbVie COM 00287Y109 383,671 7,930 2.11 41,521 3.13 0.1129
2021-02-09 2020-12-31 13F AbbVie COM 00287Y109 375,741 186,084 98.12 40,261 142.36 0.1173
2020-12-04 2020-09-30 13F/A-1 AbbVie COM 00287Y109 189,657 -5,900 -3.02 16,612 -13.48 0.0529
2020-11-12 2020-09-30 13F AbbVie COM 00287Y109 189,657 -5,900 16,612 51,503.0795
2020-08-14 2020-06-30 13F/A-1 AbbVie COM 00287Y109 195,557 14,813 8.20 19,200 39.42 0.0669
2020-08-10 2020-06-30 13F AbbVie COM 00287Y109 195,557 14,813 19,200 65,227.2263
2020-05-12 2020-03-31 13F AbbVie COM 00287Y109 180,744 -18,110 -9.11 13,771 -21.78 0.0699
2020-02-13 2019-12-31 13F AbbVie COM 00287Y109 198,854 28,163 16.50 17,606 36.22 0.0680
2019-11-08 2019-09-30 13F AbbVie COM 00287Y109 170,691 -3,466 -1.99 12,925 2.05 0.0606
2019-08-07 2019-06-30 13F AbbVie COM 00287Y109 174,157 -4,105 -2.30 12,665 -11.84 0.0610
2019-05-13 2019-03-31 13F AbbVie COM 00287Y109 178,262 -3,788 -2.08 14,366 -14.40 0.0706
2019-02-12 2018-12-31 13F AbbVie COM 00287Y109 182,050 -255 -0.14 16,783 -2.66 0.0842
2018-11-13 2018-09-30 13F AbbVie COM 00287Y109 182,305 7,806 4.47 17,242 6.65 0.0841
2018-08-13 2018-06-30 13F AbbVie COM 00287Y109 174,499 65,367 59.90 16,167 56.52 0.0756
2018-05-11 2018-03-31 13F AbbVie COM 00287Y109 109,132 -33,650 -23.57 10,329 -25.20 0.0513
2018-02-12 2017-12-31 13F AbbVie COM 00287Y109 142,782 -36,237 -20.24 13,808 -13.20 0.0681
2017-11-09 2017-09-30 13F AbbVie COM 00287Y109 179,019 -21,263 -10.62 15,908 9.54 0.0813
2017-08-11 2017-06-30 13F AbbVie COM 00287Y109 200,282 -59,995 -23.05 14,522 -14.37 0.0794
2017-05-11 2017-03-31 13F AbbVie COM 00287Y109 260,277 44,523 20.64 16,960 25.53 0.0748
2017-02-09 2016-12-31 13F AbbVie COM 00287Y109 215,754 31,015 16.79 13,511 15.96 0.0673
2016-11-14 2016-09-30 13F AbbVie COM 00287Y109 184,739 -29,755 -13.87 11,651 -12.26 0.0542
2016-08-12 2016-06-30 13F AbbVie COM 00287Y109 214,494 -15,827 -6.87 13,279 0.93 0.0680
2016-05-13 2016-03-31 13F AbbVie COM 00287Y109 230,321 -61,244 -21.01 13,156 -23.83 0.0886
2016-02-12 2015-12-31 13F AbbVie COM 00287Y109 291,565 9,932 3.53 17,272 12.71 0.1370
2015-11-12 2015-09-30 13F AbbVie COM 00287Y109 281,633 -2,833 -1.00 15,324 -19.82 0.1177
2015-08-12 2015-06-30 13F AbbVie COM 00287Y109 284,466 24,912 9.60 19,113 25.79 0.1130
2015-05-14 2015-03-31 13F AbbVie COM 00287Y109 259,554 17,416 7.19 15,194 -4.11 0.0877
2015-02-13 2014-12-31 13F AbbVie COM 00287Y109 242,138 -73,642 -23.32 15,846 -13.12 0.0985
2014-11-14 2014-09-30 13F AbbVie COM 00287Y109 315,780 36,314 12.99 18,239 15.63 0.0966
2014-08-14 2014-06-30 13F AbbVie COM 00287Y109 279,466 -26,013 -8.52 15,773 0.45 0.0728
2014-05-08 2014-03-31 13F ABBVIE COM 00287Y109 305,479 65,142 27.10 15,702 23.72 0.0779
2014-02-12 2013-12-31 13F ABBVIE COM 00287Y109 240,337 -26,516 -9.94 12,692 6.33 0.0641
2013-11-14 2013-09-30 13F ABBVIE COM 00287Y109 266,853 13,587 5.36 11,936 14.00 0.0607
2013-08-14 2013-06-30 13F ABBVIE COM 00287Y109 253,266 253,266 10,470 0.0570
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.